Supply Chain Excellence: Protecting products and patients through an intelligent supply chain
How to leverage compliance, maximize operational performance and minimize supply chain threats to patients and pharmaceutical brands
Sign up now to secure your complimentary place at this training session
Product counterfeiting and diversion are among the biggest threats facing both pharmaceutical brands and patient safety today.
This highly lucrative crime, which is estimated to be worth more than $200bn in annual sales, is being targeted by criminals who are becoming more efficient at subverting supply chain security as they chase illicit profits.
To tackle this threat, companies need to ensure smooth operations on the packaging line, use data to guide strategic decision-making across the supply chain and build stronger brand protection in the marketplace. This requires real-time abilities to discover and mitigate issues.
In this exclusive webinar, Steve Tallant, Systech Senior Director of Product Marketing, will share best practices on how to achieve an intelligent supply chain that can protect your products and patients from increasing levels of risk. All of this founded on making the most of pharmaceutical manufacturer’s investment in serialization compliance.
Steve will be joined in the session by David Yingling, Brand Protection and Product Security at Johnson & Johnson, who will discuss his role in protecting Johnson & Johnson brands from illicit activity and how the company has been working to enhance supply chain security.
Also joining the session will be Dr. Mark Willis of Willis QS Consulting and Author of Counterfeit Pharmaceuticals: Are U.S. Consumers Aware of the Potential Risks?
Attendees to this informative training session will learn:
- How to gather actionable risk intelligence from operational data.
- Techniques to strategically identify trends and potential threats in the market.
- The impact of intelligent and connected packaging.
- How to build in layers of security with end-to-end visibility.
- Best practices to protect your brand and ensure safe and secure supply.
Sign up now to secure your place.
The Supply Chain Excellence series brings together thought leaders across the pharmaceutical logistics industry to share exclusive insight.
Meet your trainers for this session:
Steve Tallant, Senior Director of Product Marketing at Systech
Steve is a brand marketing and product management expert with over 25 years of experience. He’s worked in a myriad of vertical industries with enabling technologies including anti-counterfeiting, supply chain and product lifecycle management. As a thought leader, Steve has written several white papers and is a frequent contributor of content to global industry publications across pharmaceutical and consumer packaged goods industries. His specialty areas include supply chain security, traceability, blockchain and brand/consumer protection.
David Yingling, Brand Protection and Product Security at Johnson & Johnson
David is a Senior Manager focused on product security at Johnson & Johnson based in Raritan, New Jersey. His role involves protecting J&J brands from illicit activity and working to enhance supply chain security. David has been with the company for 12 years and is currently developing new innovative strategies that center on disruptive technology and putting the customer first. He works to deliver high-value digital solutions that solve business problems and drive growth for J&J.
Dr. Mark Willis, Willis QS Consulting, Author of Counterfeit Pharmaceuticals: Are U.S. Consumers Aware of the Potential Risks?
Mark is a seasoned pharmaceuticals and medical device professional with more than 20 years’ experience in the industry. He has experience leading global regulatory programs as both a project manager (PMP) and as a software quality engineer participant (certified SQE and Quality Auditor). With a doctorate in law and public policy, as well as a participant in the construction of the recent ISO 9001 update, Mark has provided consultation on how to “right size” an organization's regulatory compliance so that its software implementations are able to meet its needs without distracting from daily operations. As a professor at Northeastern University, Bunker Hill College, and Massachusetts College of Pharmacy and Health Sciences (MCPHS), Mark has been training and mentoring the next generation of project managers with a concentration on execution within a regulated environment as well as health economics. Mark currently works with global health authority agencies, as well as the UN and USAID to conduct research for technological solutions such as Blockchain and PCIDs to secure the pharmaceutical supply chain and is the author of Counterfeit Pharmaceuticals: Are the U.S. Consumers Aware of the Potential Risks?
